Brief: Fulcrum Therapeutics Q1 Basic EPS USD -0.43
13/05/2024 12:00
May 13 (Reuters) - Fulcrum Therapeutics Q1 net income USD -26.87 million. * Q1 operating income USD -29.834 million vs. IBES estimate USD -29.6 million * Q1 operating expenses USD 29.834 million
Recent news on Fulcrum Therapeutics
See all newsFulcrum down after announcing restructuring, plans to cut 85% jobs
Brief: Fulcrum Therapeutics Approves Restructuring Plan After Discontinuing Pociredir For Sickle Cell Disease
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
Fulcrum falls after discontinuing sickle cell drug program